This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Chavanne, F. Articles by Stefanini, M. Search for Related Content PubMed PubMed Citation Articles by Chavanne, F. Articles by Stefanini, M.

Mutations in the XPC Gene in Families with Xeroderma Pigmentosum and Consequences at the Cell, Protein, and Transcript Levels¹

Istituto di Genetica Biochimica ed Evoluzionistica CNR, 27100 Pavia, Italy [F. C., D. P., T. N., M. S.], and MRC Cell Mutation Unit, Sussex University, Falmer, Brighton BN1 9RR, United Kingdom [B. C. B., A. B., A. R. L.]

Xeroderma pigmentosum (XP)-C is one of the more common complementation groups of XP, but causative mutations have thus far been reported for only six cases (S. G. Khan et al., J. Investig. Dermatol., 115: 791–796, 1998; L. Li et al., Nat. Genet., 5: 413–417, 1993). We have now extended this analysis by investigating the genomic and coding sequence of the XPC gene, the level of expression of the XPC transcript and the status of the XPC protein in 12 unrelated patients, including all of the 8 Italian XP-C cases identified thus far and in 13 of their parents. Eighteen mutations were detected in the open reading frame of the XPC gene, 13 of which are relevant for the pathological phenotype. The mutations are distributed across the gene, with no indication of any hotspots or founder effects. Only 1 of the 13 relevant changes is a missense mutation, the remainder causing protein truncations as a result of nonsense mutations (3), frameshifts (6), deletion (1) or splicing abnormalities (2). These findings indicate that the XPC gene is not essential for cell proliferation and viability and that mutations causing minor structural alterations may not give an XP phenotype and may not, therefore, be identified clinically. XP13PV was the only patient carrying a missense mutation (Trp690Ser on the paternal allele). This was also the only patient in which the XPC transcript was present at a normal level and the XPC protein was detectable, although at a lower than normal level. No quantitative alterations in the transcript or protein levels were detected in the XP-C heterozygous parents. However, the expression of the normal allele predominated in all of them, except the father of XP13PV, which suggests the existence of a possible mechanism for monitoring the amount of the XPC protein.

This article has been cited by other articles:

				B. M. Bernardes de Jesus, M. Bjoras, F. Coin, and J. M. Egly Dissection of the Molecular Defects Caused by Pathogenic Mutations in the DNA Repair Factor XPC Mol. Cell. Biol., December 1, 2008; 28(23): 7225 - 7235. [Abstract] [Full Text] [PDF]

				D. Hoogstraten, S. Bergink, J. M. Y. Ng, V. H. M. Verbiest, M. S. Luijsterburg, B. Geverts, A. Raams, C. Dinant, J. H. J. Hoeijmakers, W. Vermeulen, et al. Versatile DNA damage detection by the global genome nucleotide excision repair protein XPC J. Cell Sci., September 1, 2008; 121(17): 2850 - 2859. [Abstract] [Full Text] [PDF]

				C F Arlett, M H L Green, P B Rogers, A R Lehmann, and P N Plowman Minimal ionizing radiation sensitivity in a large cohort of xeroderma pigmentosum fibroblasts Br. J. Radiol., January 1, 2008; 81(961): 51 - 58. [Abstract] [Full Text] [PDF]

				G. Yasuda, R. Nishi, E. Watanabe, T. Mori, S. Iwai, D. Orioli, M. Stefanini, F. Hanaoka, and K. Sugasawa In Vivo Destabilization and Functional Defects of the Xeroderma Pigmentosum C Protein Caused by a Pathogenic Missense Mutation Mol. Cell. Biol., October 1, 2007; 27(19): 6606 - 6614. [Abstract] [Full Text] [PDF]

				F. Marini, T. Nardo, M. Giannattasio, M. Minuzzo, M. Stefanini, P. Plevani, and M. M. Falconi DNA nucleotide excision repair-dependent signaling to checkpoint activation PNAS, November 14, 2006; 103(46): 17325 - 17330. [Abstract] [Full Text] [PDF]

				C F Arlett, P N Plowman, P B Rogers, C N Parris, F Abbaszadeh, M H L Green, T J McMillan, C Bush, N Foray, and A R Lehmann Clinical and cellular ionizing radiation sensitivity in a patient with xeroderma pigmentosum. Br. J. Radiol., June 1, 2006; 79(942): 510 - 517. [Abstract] [Full Text] [PDF]

				S. G. Khan, K.-S. Oh, T. Shahlavi, T. Ueda, D. B. Busch, H. Inui, S. Emmert, K. Imoto, V. Muniz-Medina, C. C. Baker, et al. Reduced XPC DNA repair gene mRNA levels in clinically normal parents of xeroderma pigmentosum patients Carcinogenesis, January 1, 2006; 27(1): 84 - 94. [Abstract] [Full Text] [PDF]

				M. D'Errico, M. Teson, A. Calcagnile, T. Nardo, N. De Luca, C. Lazzari, S. Soddu, G. Zambruno, M. Stefanini, and E. Dogliotti Differential Role of Transcription-Coupled Repair in UVB-Induced Response of Human Fibroblasts and Keratinocytes Cancer Res., January 15, 2005; 65(2): 432 - 438. [Abstract] [Full Text] [PDF]

				S. G. Khan, A. Metin, E. Gozukara, H. Inui, T. Shahlavi, V. Muniz-Medina, C. C. Baker, T. Ueda, J. R. Aiken, T. D. Schneider, et al. Two essential splice lariat branchpoint sequences in one intron in a xeroderma pigmentosum DNA repair gene: mutations result in reduced XPC mRNA levels that correlate with cancer risk Hum. Mol. Genet., February 1, 2004; 13(3): 343 - 352. [Abstract] [Full Text] [PDF]

				V. Rapic-Otrin, V. Navazza, T. Nardo, E. Botta, M. McLenigan, D. C. Bisi, A. S. Levine, and M. Stefanini True XP group E patients have a defective UV-damaged DNA binding protein complex and mutations in DDB2 which reveal the functional domains of its p48 product Hum. Mol. Genet., July 1, 2003; 12(13): 1507 - 1522. [Abstract] [Full Text] [PDF]

				V. Anantharaman, E. V. Koonin, and L. Aravind Peptide-N-glycanases and DNA repair proteins, Xp-C/Rad4, are, respectively, active and inactivated enzymes sharing a common transglutaminase fold Hum. Mol. Genet., August 1, 2001; 10(16): 1627 - 1630. [Abstract] [Full Text] [PDF]

				S. G. Khan, E.J. Metter, R. E. Tarone, V. A. Bohr, L. Grossman, M. Hedayati, S. J. Bale, S. Emmert, and K. H. Kraemer A new xeroderma pigmentosum group C poly(AT) insertion/deletion polymorphism Carcinogenesis, October 1, 2000; 21(10): 1821 - 1825. [Abstract] [Full Text] [PDF]